|
EGLN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.72010011473867E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10189635194047E-11 |
| Normal-vs-Stage2 |
5.032900E-04 |
| Normal-vs-Stage3 |
7.157100E-03 |
| Normal-vs-Stage4 |
1.918610E-01 |
| Stage1-vs-Stage2 |
5.698000E-01 |
| Stage1-vs-Stage3 |
4.610000E-02 |
| Stage1-vs-Stage4 |
6.1839000000008E-05 |
| Stage2-vs-Stage3 |
7.580400E-02 |
| Stage2-vs-Stage4 |
7.358000E-03 |
| Stage3-vs-Stage4 |
1.684560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93350002675174E-10 |
| Normal-vs-AfricanAmerican |
1.984590E-01 |
| Normal-vs-Asian |
2.255000E-01 |
| Caucasian-vs-AfricanAmerican |
6.814700E-04 |
| Caucasian-vs-Asian |
8.414600E-01 |
| AfricanAmerican-vs-Asian |
2.853600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27430000002238E-07 |
| Normal-vs-Female |
1.61659999831087E-08 |
| Male-vs-Female |
1.271200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.919000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.11149999981741E-07 |
| Normal-vs-Age(61-80Yrs) |
1.79559999979872E-07 |
| Normal-vs-Age(81-100Yrs) |
1.860000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.440300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.443840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.047250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.704200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.625800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.720800E-03 |
| Normal-vs-Grade 2 |
1.71289982198175E-10 |
| Normal-vs-Grade 3 |
3.80440000002924E-06 |
| Normal-vs-Grade 4 |
7.857400E-01 |
| Grade 1-vs-Grade 2 |
5.080600E-01 |
| Grade 1-vs-Grade 3 |
9.535800E-02 |
| Grade 1-vs-Grade 4 |
9.594400E-04 |
| Grade 2-vs-Grade 3 |
2.756300E-02 |
| Grade 2-vs-Grade 4 |
9.96090000038308E-07 |
| Grade 3-vs-Grade 4 |
3.140200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
3.187700E-02 |
| ccA subtype-vs-ccB subtype |
7.8438999739916E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.26769999964883E-07 |
| Normal-vs-N1 |
5.595400E-01 |
| N0-vs-N1 |
3.993800E-01 |
|
|
